willdate

13 POSTS 0 COMMENTS

Impulse Dynamics secures funding to commercialise Optimizer Smart

Impulse Dynamics has announced the completion of an US$80.25 million Series D financing round with new investors. Proceeds will be used primarily to facilitate...

Tackling focal VT may improve catheter ablation in structural heart disease

Uncovering and abolishing focal ventricular tachycardia (VT) may further improve outcomes of catheter ablation in the treatment of structural heart disease, a study published...

VivaLnk’s multi-vital wearable sensor and software development kit receive CE mark

VivaLnk has announced it has received the class IIa medical device CE mark for its multi-vital medical wearable sensor and software development kit (SDK). The...

PADIT score predicts CIED infection risk

Five independent predictors of cardiac implantable electronic device (CIED) infection have been identified which could be used to aid physicians and patients in decision-making...

Pedro Brugada

With his brothers Josep and Ramon, Pedro Brugada discovered the syndrome that bears their name. He reflects on his career highlights with Cardiac Rhythm...

AHA 2019: Correvio announces new data from SPECTRUM Brinavess study

Cardiac Rhythm news for specialists
Correvio announced the presentation of new data from the SPECTRUM study evaluating Brinavess (vernakalant hydrochloride, IV), an antiarrhythmic drug for the rapid conversion of...

Cardiac Rhythm News Issue 46 – October 2019

Highlights: ESC guidelines on supraventricular tachycardias underline the pivotal role of catheter ablation therapy Study suggests increased use of DOACs in AF leads to...

Left atrial appendage closure associated with a decreased stroke risk in...

Left atrial appendage closure (LAAC) via implanted device was associated with a decreased risk of admission for stroke, compared with the expected risk without...

First patients treated using integrated navigation technology from Stereotaxis and ADAS...

Stereotaxis and ADAS 3D Medical have announced that the first patients have been treated with the integration of ADAS 3D’s advanced preoperative substrate mapping...

CardioFocus treats first patients with HeartLight endoscopic ablation system in France

CardioFocus has announced that the first patients in France have been treated in the University Public Hospital of Nancy with the HeartLight endoscopic ablation...

Cardiva Medical announces publication of data from AMBULATE pivotal study

Cardiva Medical has said that results from the AMBULATE pivotal study demonstrate the safety and efficacy of its VASCADE MVP venous vascular closure system...

Bardy Diagnostics wins digital health pitch session at ESC Congress

Bardy Diagnostics announced that it was selected as winner of the ‘Remote Monitoring in Arrhythmias’ Technology and Innovation Pitch Session held as part of...

Low bleeding and cardiovascular events in elderly NVAF patients using edoxaban,...

Cardiac Rhythm news for specialists
Daiichi Sankyo has announced one-year follow-up results from an analysis of 12,574 European non-valvular atrial fibrillation (NVAF) patients, mostly elderly, treated with edoxaban (Lixiana)....